Viollet B - Search Results

1

AMPK in skeletal muscle function and metabolism.

Kjøbsted R, Hingst JR, Fentz J, Foretz M, Sanz MN, Pehmøller C, Shum M, Marette A, Mounier R, Treebak JT, Wojtaszewski JFP, Viollet B, Lantier L. Kjøbsted R, et al. Among authors: viollet b. FASEB J. 2018 Apr;32(4):1741-1777. doi: 10.1096/fj.201700442R. Epub 2018 Jan 5. FASEB J. 2018. PMID: 29242278 Free PMC article. Review.

., Marette, A., Mounier, R., Treebak, J. T., Wojtaszewski, J. F. P., Viollet, B., Lantier, L. AMPK in skeletal muscle function and metabolism....

., Marette, A., Mounier, R., Treebak, J. T., Wojtaszewski, J. F. P., Viollet, B., Lantier, L. AMPK in skeletal muscle function …

2

The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.

Viollet B, Andreelli F, Jørgensen SB, Perrin C, Geloen A, Flamez D, Mu J, Lenzner C, Baud O, Bennoun M, Gomas E, Nicolas G, Wojtaszewski JF, Kahn A, Carling D, Schuit FC, Birnbaum MJ, Richter EA, Burcelin R, Vaulont S. Viollet B, et al. J Clin Invest. 2003 Jan;111(1):91-8. doi: 10.1172/JCI16567. J Clin Invest. 2003. PMID: 12511592 Free PMC article.

3

A possible role for AMP-activated protein kinase in exercise-induced glucose utilization: insights from humans and transgenic animals.

Nielsen JN, Jørgensen SB, Frøsig C, Viollet B, Andreelli F, Vaulont S, Kiens B, Richter EA, Wojtaszewski JF. Nielsen JN, et al. Among authors: viollet b. Biochem Soc Trans. 2003 Feb;31(Pt 1):186-90. doi: 10.1042/bst0310186. Biochem Soc Trans. 2003. PMID: 12546682 Review.

4

Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models.

Viollet B, Andreelli F, Jørgensen SB, Perrin C, Flamez D, Mu J, Wojtaszewski JF, Schuit FC, Birnbaum M, Richter E, Burcelin R, Vaulont S. Viollet B, et al. Biochem Soc Trans. 2003 Feb;31(Pt 1):216-9. doi: 10.1042/bst0310216. Biochem Soc Trans. 2003. PMID: 12546688 Review.

5

Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.

Jørgensen SB, Viollet B, Andreelli F, Frøsig C, Birk JB, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JF. Jørgensen SB, et al. Among authors: viollet b. J Biol Chem. 2004 Jan 9;279(2):1070-9. doi: 10.1074/jbc.M306205200. Epub 2003 Oct 21. J Biol Chem. 2004. PMID: 14573616 Free article.

6

The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading.

Jørgensen SB, Nielsen JN, Birk JB, Olsen GS, Viollet B, Andreelli F, Schjerling P, Vaulont S, Hardie DG, Hansen BF, Richter EA, Wojtaszewski JF. Jørgensen SB, et al. Among authors: viollet b. Diabetes. 2004 Dec;53(12):3074-81. doi: 10.2337/diabetes.53.12.3074. Diabetes. 2004. PMID: 15561936

7

Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver.

Foretz M, Ancellin N, Andreelli F, Saintillan Y, Grondin P, Kahn A, Thorens B, Vaulont S, Viollet B. Foretz M, et al. Among authors: viollet b. Diabetes. 2005 May;54(5):1331-9. doi: 10.2337/diabetes.54.5.1331. Diabetes. 2005. PMID: 15855317

8

Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.

Jørgensen SB, Wojtaszewski JF, Viollet B, Andreelli F, Birk JB, Hellsten Y, Schjerling P, Vaulont S, Neufer PD, Richter EA, Pilegaard H. Jørgensen SB, et al. Among authors: viollet b. FASEB J. 2005 Jul;19(9):1146-8. doi: 10.1096/fj.04-3144fje. Epub 2005 May 5. FASEB J. 2005. PMID: 15878932

9

Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin.

Andreelli F, Foretz M, Knauf C, Cani PD, Perrin C, Iglesias MA, Pillot B, Bado A, Tronche F, Mithieux G, Vaulont S, Burcelin R, Viollet B. Andreelli F, et al. Among authors: viollet b. Endocrinology. 2006 May;147(5):2432-41. doi: 10.1210/en.2005-0898. Epub 2006 Feb 2. Endocrinology. 2006. PMID: 16455782

10

[From cancer to diabetes treatment : the tumor suppressor LKB1 as a new pharmacological target].

Foretz M, Guigas B, Viollet B. Foretz M, et al. Among authors: viollet b. Med Sci (Paris). 2006 Apr;22(4):348-50. doi: 10.1051/medsci/2006224348. Med Sci (Paris). 2006. PMID: 16597397 Free article. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page